Phencyclidine binding to striatal cocaine receptors

Area of Science:

• Neuroscience
• Pharmacology
• Molecular Biology

Background:

• Dopamine transporters (DATs) are crucial for regulating dopaminergic neurotransmission.
• The cocaine receptor on DATs is a key target for psychostimulant drugs.
• Phencyclidine (PCP) is a dissociative anesthetic with complex neurochemical effects.

Purpose of the Study:

• To investigate the interaction of PCP and related compounds with the cocaine receptor on dopamine transporters.
• To determine the relative affinities of PCP at the cocaine receptor versus its primary binding site.
• To assess the potential role of cocaine receptor interaction in mediating PCP's behavioral effects.

Main Methods:

• Inhibition of 3H-mazindol binding assays were used to measure compound affinity.
• Radioligand binding studies were performed on dopamine transporters.
• Comparative affinity analysis was conducted for PCP at different receptor sites.

Main Results:

• PCP and related compounds demonstrated inhibitory effects on 3H-mazindol binding to the dopamine transporter's cocaine receptor.
• PCP exhibited a lower affinity (Ki = 1.59 microM) for the cocaine receptor compared to its affinity at its primary binding site (Ki ≈ 0.12 microM).

Conclusions:

• The findings suggest that while PCP interacts with the cocaine receptor, this interaction may not be the primary mechanism underlying its behavioral effects.
• Further research is required to definitively establish the role of the cocaine receptor in mediating the actions of PCP.
• The study highlights the complex pharmacology of PCP and its potential interactions with multiple neurotransmitter systems.